Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents
- 5 March 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (12) , 4244-4252
Abstract
Drug resistance to chemotherapeutics is a recurrent issue plaguing many cancer treatment regimens. To circumvent resistance issues, we have designed a new class of macromolecules as self-contained chemotherapeutic agents. The macromolecular chemotherapeutic agents readily self-assemble into well-defined nanoparticles and show excellent activity in vitro against multiple cancer cell lines. These cationic polymers function by selectively binding and lysing cancer cell membranes. As a consequence of this mechanism, they exhibit significant potency against drug-resistant cancer cells and cancer stem cells, prevent cancer cell migration, and do not induce resistance onset following multiple treatment passages. Concurrent experiments with the small-molecule chemotherapeutic, doxorubicin, show aggressive resistance onset in cancer cells, a lack of efficacy against drug-resistant cancer cell lines, and a failure to prevent cancer cell migration. Additionally, the polymers showed anticancer efficacy in a hepatocellular carcinoma patient derived xenograft mouse model. Overall, these results demonstrate a new approach to designing anticancer therapeutics utilizing macromolecular compounds.Keywords
Funding Information
- Translational and Clinical Research Grant (NMRC/TCR/014-NUHS/2015)
- Singapore National Research Foundation Fellowship (NRF-NRFF2017-03)
This publication has 41 references indexed in Scilit:
- Anticancer activity of a synthetic peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridisInternational Journal of Oncology, 2013
- Properties of Tumor Spheroid Growth Exhibited by Simple Mathematical ModelsFrontiers in Oncology, 2013
- Piscidin-1, an Antimicrobial Peptide from Fish (Hybrid Striped BassMorone saxatilisxM. chrysops), Induces Apoptotic and Necrotic Activity in HT1080 CellsZoological Science, 2012
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxiaProceedings of the National Academy of Sciences, 2012
- Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based NanoparticlesBiomacromolecules, 2011
- Self-assembled polymer nanostructures for delivery of anticancer therapeuticsNano Today, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomasProceedings of the National Academy of Sciences, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistanceOncogene, 2001